Literature DB >> 12425567

Lansoprazole-associated microscopic colitis: a case series.

Robert D Thomson1, Lisa S Lestina, Steven P Bensen, Arifa Toor, Yogesh Maheshwari, Nora R Ratcliffe.   

Abstract

Lansoprazole is a potent proton pump inhibitor that has been well tolerated with minimal serious adverse events. One of the most commonly reported side effects is diarrhea in 3-8% of study patients. During 1997, approximately 850 veterans at our institution had their proton pump inhibitor converted from omeprazole to lansoprazole because of a formulary change. A number of patients subsequently developed chronic watery diarrhea. While evaluating six of these patients, we discovered microscopic colitis that resolved with discontinuation of lansoprazole. The diarrhea was described as three to 10 loose, nonbloody bowel movements per day with some abdominal cramping. Colonoscopy in five patients and flexible sigmoidoscopy in one patient revealed normal colonic mucosa, but random biopsies all supported microscopic colitis (five cases of lymphocytic colitis and one case of collagenous colitis). Complete symptom resolution occurred in all patients within 4 to 10 days of discontinuing lansoprazole. In all patients, follow-up biopsies demonstrated normalization of the colonic histology. This is the first published case series of patients with microscopic colitis that correlated clinically and histologically with the initiation and discontinuation of lansoprazole.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12425567     DOI: 10.1111/j.1572-0241.2002.07066.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  23 in total

1.  The rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England: cohort studies.

Authors:  R M Martin; N R Dunn; S Freemantle; S Shakir
Journal:  Br J Clin Pharmacol       Date:  2000-10       Impact factor: 4.335

2.  Collagenous Colitis Associated with Rabeprazole in a Peritoneal Dialysis Patient.

Authors:  Masaru Murasawa; Tsutomu Sakurada; Daisuke Oishi; Tomo Suzuki; Naoto Tominaga; Hiroo Kawarazaki; Sayuri Shirai; Yugo Shibagaki; Kenjiro Kimura
Journal:  Perit Dial Int       Date:  2015 Sep-Oct       Impact factor: 1.756

3.  Clostridium difficile colitis: a marker for ischemic colitis?

Authors:  Richard Fiddian-Green
Journal:  CMAJ       Date:  2004-11-23       Impact factor: 8.262

4.  Effects of esomeprazole magnesium on nonsteroidal anti-inflammatory drug gastropathy.

Authors:  Timothy R Koch; Ann Petro; Marcus Darrabie; Emmanuel C Opara
Journal:  Dig Dis Sci       Date:  2005-01       Impact factor: 3.199

5.  Microscopic colitis impacts quality of life in older people.

Authors:  Olayinka Ayodele Ogundipe; Amy Campbell
Journal:  BMJ Case Rep       Date:  2019-06-06

6.  Collagenous colitis appeared after 6-year administration of lansoprazole.

Authors:  Koji Sawada; Mikihiro Fujiya; Kentaro Itabashi; Yasuyuki Suzuki; Koji Kubo; Toshie Nata; Nobuhiro Ueno; Yuhei Inaba; Kentaro Moriichi; Kotaro Okamoto; Katsuya Ikuta; Hiroki Tanabe; Yusuke Mizukami; Yoshitake Takagi; Yutaka Kohgo
Journal:  Clin J Gastroenterol       Date:  2009-11-28

7.  Microscopic colitides: a single center experience in Mexico.

Authors:  Alberto Rubio-Tapia; Julio Martínez-Salgado; Jorge García-Leiva; Braulio Martínez-Benítez; Misael Uribe
Journal:  Int J Colorectal Dis       Date:  2007-01-23       Impact factor: 2.571

8.  Prevalence of microscopic colitis in patients with diarrhea of unknown etiology in Turkey.

Authors:  Levent Erdem; Sadik Yildirim; Nihat Akbayir; Banu Yilmaz; Necati Yenice; Orhan-Sami Gultekin; Onder Peker
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

9.  Identification of Menopausal and Reproductive Risk Factors for Microscopic Colitis-Results From the Nurses' Health Study.

Authors:  Kristin E Burke; Ashwin N Ananthakrishnan; Paul Lochhead; Po-Hong Liu; Ola Olen; Jonas F Ludvigsson; James M Richter; Shelley S Tworoger; Andrew T Chan; Hamed Khalili
Journal:  Gastroenterology       Date:  2018-08-23       Impact factor: 22.682

10.  Proton pump inhibitors are not the key for therapying non-steroidal anti-inflammatory drugs-induced small intestinal injury.

Authors:  Shuo Zhang; Guan-qun Chao; Bin Lu
Journal:  Rheumatol Int       Date:  2013-04-19       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.